Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes

被引：1
|
作者：
Wasif, Uzayr [1 ]
Al-Shehab, Usmaan [2 ,3 ]
Lo, David F. F. [1 ,2 ,3 ]
机构：
[1] Rutgers State Univ, Dept Biol, New Brunswick, NJ USA
[2] Rowan Sch Osteopath Med, Dept Med, 1 Med Ctr Dr, Stratford, NJ 08084 USA
[3] APSEA, Stratford, NJ USA
来源：
JOURNAL OF DIABETES | 2023年
关键词：
D O I：
10.1111/1753-0407.13409
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes Responses
    Zhao, Houyu
    Zhuo, Lin
    Sun, Yexiang
    Shen, Peng
    Lin, Hongbo
    Zhan, Siyan
    [J]. JOURNAL OF DIABETES, 2023,
  • [2] Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes
    Idris, Iskandar
    Warren, Graham
    Donnelly, Richard
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (13) : 1005 - 1011
  • [3] Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
    Zhao, Houyu
    Zhuo, Lin
    Sun, Yexiang
    Shen, Peng
    Lin, Hongbo
    Zhan, Siyan
    [J]. JOURNAL OF DIABETES, 2023, 15 (02) : 97 - 109
  • [4] Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
    Habib, Zeina A.
    Havstad, Suzanne L.
    Wells, Karen
    Divine, George
    Pladevall, Manel
    Williams, L. Keoki
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 592 - 600
  • [5] The Association between Metformin Use and Risk of Developing Severe Dementia among AD Patients with Type 2 Diabetes
    Xue, Ying
    Xie, Xiangqun
    [J]. BIOMEDICINES, 2023, 11 (11)
  • [6] Association between hypoglycemia and dementia in patients with type 2 diabetes
    Sheen, Yi-Jing
    Sheu, Wayne H. H.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 116 : 279 - 287
  • [7] Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
    Chen, Kuan-Chan
    Chung, Chi-Hsiang
    Lu, Chieh-Hua
    Tzeng, Nian-Sheng
    Lee, Chien-Hsing
    Su, Sheng-Chiang
    Kuo, Feng-Chih
    Liu, Jhih-Syuan
    Hsieh, Chang-Hsun
    Chien, Wu-Chien
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [8] Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
    Houyu Zhao
    Lin Zhuo
    Yexiang Sun
    Peng Shen
    Hongbo Lin
    Siyan Zhan
    [J]. npj Parkinson's Disease, 8
  • [9] Thiazolidinedione use and risk of Parkinson's disease in patients with type 2 diabetes mellitus
    Zhao, Houyu
    Zhuo, Lin
    Sun, Yexiang
    Shen, Peng
    Lin, Hongbo
    Zhan, Siyan
    [J]. NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [10] Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry
    Yang, Xilin
    So, Wing-Yee
    Ma, Ronald C. W.
    Yu, Linda W. L.
    Kong, Alice P. S.
    Lee, Heung Man
    Xu, Gang
    Ozaki, Risa
    Ko, Gary T. C.
    Chan, Juliana C. N.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (01) : E11 - E15
12345